Cloud-clone
SKU:SEF709Hu
ELISA Kit for Peptidyl Arginine Deiminase Type IV (PADI4)
ELISA Kit for Peptidyl Arginine Deiminase Type IV (PADI4)
Couldn't load pickup availability
Enzyme-linked immunosorbent assay for Antigen Detection.
Product No.
SEF709Hu
Organism Species
Homo sapiens (Human).
Sample Type
Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Test Method
Double-antibody Sandwich
Assay Length
3h
Detection Range
0.312-20ng/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 0.133ng/mL.
UOM
48T 96T 96T*5 96T*10 96T*100
Specificity
This assay has high sensitivity and excellent specificity for detection of Peptidyl Arginine Deiminase Type IV (PADI4).
No significant cross-reactivity or interference between Peptidyl Arginine Deiminase Type IV (PADI4) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Peptidyl Arginine Deiminase Type IV (PADI4) and the recovery rates were calculated by comparing the measured value to the expected amount of Peptidyl Arginine Deiminase Type IV (PADI4) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 82-94 | 89 |
| EDTA plasma(n=5) | 78-94 | 89 |
| heparin plasma(n=5) | 86-95 | 91 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Peptidyl Arginine Deiminase Type IV (PADI4) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Peptidyl Arginine Deiminase Type IV (PADI4) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Peptidyl Arginine Deiminase Type IV (PADI4) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 97-104% | 85-94% | 83-96% | 90-104% |
| EDTA plasma(n=5) | 85-102% | 78-98% | 98-105% | 91-99% |
| heparin plasma(n=5) | 98-105% | 88-103% | 78-97% | 78-94% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
| Standard | 2 | Standard Diluent | 1×20mL |
| Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
| Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
| TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
| Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.
| Magazine | Citations |
| Arthritis Res Ther. | Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility Pubmed:Pmc4229860 |
| Journal of Molecular Cell Biology | Peptidylarginine deiminase 4 concentration, but not polymorphisms, is associated with ICU mortality in septic shock patients Pubmed:30044533 |
| Journal of Inflammation Research | Release of active peptidylarginine deiminase into the circulation during acute inflammation induced by coronary artery bypass surgery Pubmed: 31213874 |
| Revista da Associacao Medica Brasileira | Evaluation of peptidylarginine deiminase 4 and PADI4 polymorphisms in sepsis-induced acute kidney injury |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPF709Hu01 | Recombinant Peptidyl Arginine Deiminase Type IV (PADI4) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAF709Hu01 | Polyclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) | WB; IHC; ICC; IP. |
| MAF709Hu21 | Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) | WB; IHC; ICC; IP. |
| MAF709Hu22 | Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) | WB; IHC; ICC; IP. |
| MAF709Hu23 | Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) | WB; IHC; ICC; IP. |
| MAF709Hu24 | Monoclonal Antibody to Peptidyl Arginine Deiminase Type IV (PADI4) | WB; IHC; ICC; IP. |
| SEF709Hu | ELISA Kit for Peptidyl Arginine Deiminase Type IV (PADI4) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMF709Hu | Magnetic Luminex Assay Kit for Peptidyl Arginine Deiminase Type IV (PADI4) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
